Uploaded July 2013 | Updated September 2026, 1 week ago
Once researchers have the results of a trial, they need to make sure that the results are made known to a variety of audiences, including doctors, trial participants, others with the condition, and policymakers.
This involves more than just presenting at conferences and publishing journal articles. This film explores how two very different trials have tried to make sure their results are shared with everyone who needs to know.
The Medical Research Council Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and #cancer, and delivering swifter and more effective translation of scientific #research into patient benefits. It does this by carrying out challenging and innovative studies, and developing and implementing methodological advances in study design, conduct and analysis.
The CTU designs and conducts innovative and challenging #clinicaltrials. It brings together the results of a number of trials which look at the same illness or condition (this is called a systematic review or meta-analysis). It also undertakes observational studies to evaluate the impact of new interventions in routine care.
The CTU's Focus is on internationally important questions, through challenging and innovative studies, concentrating on infectious diseases and cancer. It carries out methodological research to help improve how studies are designed, conducted and analysed. This innovation is inspired by challenges faced by our studies, and helps ensure scientific progress is translated into clinical benefit more rapidly and effectively.
Once researchers have the results of a trial, they need to make sure that the results are made known to a variety of audiences, including doctors, trial participants, others with the condition, and policymakers.
This involves more than just presenting at conferences and publishing journal articles. This film explores how two very different trials have tried to make sure their results are shared with everyone who needs to know.
The Medical Research Council Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and #cancer, and delivering swifter and more effective translation of scientific #research into patient benefits. It does this by carrying out challenging and innovative studies, and developing and implementing methodological advances in study design, conduct and analysis.
The CTU designs and conducts innovative and challenging #clinicaltrials. It brings together the results of a number of trials which look at the same illness or condition (this is called a systematic review or meta-analysis). It also undertakes observational studies to evaluate the impact of new interventions in routine care.
The CTU's Focus is on internationally important questions, through challenging and innovative studies, concentrating on infectious diseases and cancer. It carries out methodological research to help improve how studies are designed, conducted and analysed. This innovation is inspired by challenges faced by our studies, and helps ensure scientific progress is translated into clinical benefit more rapidly and effectively.
